346 related articles for article (PubMed ID: 28356570)
21. [The mechanism of lung tissue remodeling in the progression of idiopathic pulmonary fibrosis].
Kogan EA; Tyong FV; Demura SA
Arkh Patol; 2010; 72(4):30-6. PubMed ID: 21086635
[TBL] [Abstract][Full Text] [Related]
22. The Role of Immune Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis.
Xu Y; Lan P; Wang T
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004032
[TBL] [Abstract][Full Text] [Related]
23. Natural history of idiopathic pulmonary fibrosis.
Kim HJ; Perlman D; Tomic R
Respir Med; 2015 Jun; 109(6):661-70. PubMed ID: 25727856
[TBL] [Abstract][Full Text] [Related]
24. Emerging therapeutic interventions for idiopathic pulmonary fibrosis.
Chakraborty S; Chopra P; Ambi SV; Dastidar SG; Ray A
Expert Opin Investig Drugs; 2014 Jul; 23(7):893-910. PubMed ID: 24766571
[TBL] [Abstract][Full Text] [Related]
25. Association of HLA and cytokine gene polymorphisms with idiopathic pulmonary fibrosis.
Zhang HP; Zou J; Xie P; Gao F; Mu HJ
Kaohsiung J Med Sci; 2015 Dec; 31(12):613-20. PubMed ID: 26709222
[TBL] [Abstract][Full Text] [Related]
26. A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung.
Pulkkinen V; Salmenkivi K; Kinnula VL; Sutinen E; Halme M; Hodgson U; Lehto J; Jääskeläinen A; Piiparinen H; Kere J; Lautenschlager I; Lappalainen M; Myllärniemi M
Ann Med; 2012 Mar; 44(2):178-86. PubMed ID: 21254895
[TBL] [Abstract][Full Text] [Related]
27. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
[TBL] [Abstract][Full Text] [Related]
28. Current advances in idiopathic pulmonary fibrosis: the pathogenesis, therapeutic strategies and candidate molecules.
Lv M; Liu Y; Ma S; Yu Z
Future Med Chem; 2019 Oct; 11(19):2595-2620. PubMed ID: 31633402
[TBL] [Abstract][Full Text] [Related]
29. [The expressions and meanings of BMP-7 and TGF-β in idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia].
Gu P; Luo B; Yi X; Zhu H; Li S; Yu X; Han F; Zhang S; Zhu X; Rui W; Qiu W; Fan D
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Sep; 37(9):664-70. PubMed ID: 25533688
[TBL] [Abstract][Full Text] [Related]
30. Serum CA 15-3 is increased in pulmonary fibrosis.
Ricci A; Mariotta S; Bronzetti E; Bruno P; Vismara L; De Dominicis C; Laganà B; Paone G; Mura M; Rogliani P; Mastrangeldo M; Sciacchitano S; Saltini C
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):54-63. PubMed ID: 19960789
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: protocol for a systematic review.
Kamiya H; Panlaqui OM
BMJ Open; 2018 Mar; 8(3):e020862. PubMed ID: 29523572
[TBL] [Abstract][Full Text] [Related]
32. Autoimmune symptoms in idiopathic pulmonary fibrosis: clinical significance.
Alhamad EH; Cal JG; AlBoukai AA; Shaik SA; Omair MA
Clin Respir J; 2016 May; 10(3):350-8. PubMed ID: 25307273
[TBL] [Abstract][Full Text] [Related]
33. Geoepidemiology of COPD and idiopathic pulmonary fibrosis.
Zeki AA; Schivo M; Chan AL; Hardin KA; Kenyon NJ; Albertson TE; Rosenquist GL; Louie S
J Autoimmun; 2010 May; 34(3):J327-38. PubMed ID: 20018478
[TBL] [Abstract][Full Text] [Related]
34. Immunologic responses to antifibrotic treatment in IPF patients.
d'Alessandro M; Bergantini L; Cameli P; Fanetti M; Alderighi L; Armati M; Refini RM; Alonzi V; Sestini P; Bargagli E
Int Immunopharmacol; 2021 Jun; 95():107525. PubMed ID: 33714885
[TBL] [Abstract][Full Text] [Related]
35. [Immunopathogenesis of idiopathic pulmonary fibrosis].
Demkow U
Pneumonol Alergol Pol; 2014; 82(1):55-60. PubMed ID: 24391072
[TBL] [Abstract][Full Text] [Related]
36. Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy.
Horowitz JC; Thannickal VJ
Treat Respir Med; 2006; 5(5):325-42. PubMed ID: 16928146
[TBL] [Abstract][Full Text] [Related]
37. Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions.
Xu X; Dai H; Wang C
Clin Respir J; 2016 Mar; 10(2):133-41. PubMed ID: 25047066
[TBL] [Abstract][Full Text] [Related]
38. Idiopathic pulmonary fibrosis: evolving concepts.
Ryu JH; Moua T; Daniels CE; Hartman TE; Yi ES; Utz JP; Limper AH
Mayo Clin Proc; 2014 Aug; 89(8):1130-42. PubMed ID: 24867394
[TBL] [Abstract][Full Text] [Related]
39. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.
Williamson JD; Sadofsky LR; Hart SP
Exp Lung Res; 2015 Mar; 41(2):57-73. PubMed ID: 25514507
[TBL] [Abstract][Full Text] [Related]
40. Dendritic Cells Are the Intriguing Players in the Puzzle of Idiopathic Pulmonary Fibrosis Pathogenesis.
Bocchino M; Zanotta S; Capitelli L; Galati D
Front Immunol; 2021; 12():664109. PubMed ID: 33995394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
